Search Results

In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer.

• Authors : Sharma, Anuradha; Sharma, Indu

• Source: Medical Oncology; Jul2023, Vol. 40 Issue 7, p1-11, 11p

Record details

Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration.

• Authors : Nwokolo, Nneka; Post, Elana; Mageau, A. Savannah

Subjects: THROMBOEMBOLISM risk factors; ANTI-HIV agents; HORMONE therapy

• Source: HIV Medicine; May2023, Vol. 24 Issue 5, p580-587, 8p

Record details

Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review.

• Authors : Ti, Angeline; Curtis, Kathryn M.

Subjects: POSTPARTUM depression; POSTPARTUM contraception; DISEASE incidence

• Source: European Journal of Contraception & Reproductive Health Care; Apr2019, Vol. 24 Issue 2, p109-116, 8p

Record details

McGill University Reports Findings in Endometrioma (Medical Management of Ovarian Endometriomas).

Subjects: ENDOMETRIOSIS; HEMOPROTEINSMONTREAL (Quebec); CENTRAL AmericaMCGILL University

• Source: Women's Health Weekly; 3/21/2024, p1220-1220, 1p

Record details

New Deep Vein Thrombosis Data Have Been Reported by Researchers at University of South Florida (Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol).

Subjects: ETHINYL estradiol; VENOUS thrombosis; ORAL contraceptivesUNIVERSITY of South Florida

• Source: Women's Health Weekly; 3/15/2024, p493-493, 1p

Record details

Recurrent decidual cast with membranous dysmenorrhea

• Authors : Jyoti; Kumari, Suman; Kumar, Devender

• Source: International Journal of Reproduction, Contraception, Obstetrics and Gynecology. February, 2019, Vol. 8 Issue 2, p738, 3 p.

Record details

Shifting from Oral Contraceptives to Norethisterone Acetate, or Vice Versa, because of Drug Intolerance: Does the Change Benefit Women with Endometriosis?

• Authors : Vercellini, Paolo; Ottolini, Federica; Frattaruolo, Maria Pina

Subjects: ORAL contraceptives; NORETHINDRONE; TREATMENT of endometriosis

• Source: Gynecologic & Obstetric Investigation; May2018, Vol. 83 Issue 3, p275-284, 10p, 5 Charts

Record details

Researchers Submit Patent Application, "Drug Delivery System For Ultra-Low Dose Estrogen Combinations And Methods And Uses Thereof", for Approval (USPTO 20230404911).

Subjects: DRUG delivery systems; PATENT applications; VAGINAL medication

• Source: Women's Health Weekly; 1/9/2024, p3507-3507, 1p

Record details

Patent Application Titled "Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen" Published Online (USPTO 20230330108).

Subjects: ORAL contraceptives; PATENT applications; ORAL medication

• Source: Women's Health Weekly; 11/9/2023, p1678-1678, 1p

Record details

Drospirenone (Slynd)-A New Progestin-Only Oral Contraceptive.

Subjects: *ORAL contraceptives; *BIOCHEMICAL mechanism of action; *PROGESTATIONAL hormones

• Source: JAMA: Journal of the American Medical Association. 5/19/2020, Vol. 323 Issue 19, p1963-1964. 2p.

Record details